CP-47497 is discontinued (DEA controlled substance, Schedule I). This product is a cannabinoid (CB1) receptor agonist. It has analgesic effects. References: Hruba L, McMahon LR. Apparent Affinity Estimates and Reversal of the Effects of Synthetic Cannabinoids AM-2201, CP-47,497, JWH-122, and JWH-250 by Rimonabant in Rhesus Monkeys. J Pharmacol Exp Ther. 2017 Aug;362(2):278-286. doi: 10.1124/jpet.117.240572. Epub 2017 May 22. PubMed PMID: 28533288; PubMed Central PMCID: PMC5502382.

纯度：≥98%

CAS：114753-51-4